[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Longeveron Inc (LGVN)

Longeveron Inc (LGVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,425
  • Shares Outstanding, K 3,188
  • Annual Sales, $ 1,200 K
  • Annual Income, $ -22,700 K
  • EBIT $ -24 M
  • EBITDA $ -22 M
  • 60-Month Beta -0.31
  • Price/Sales 18.08
  • Price/Cash Flow N/A
  • Price/Book 2.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-1.53
  • Number of Estimates 3
  • High Estimate $-1.00
  • Low Estimate $-1.90
  • Prior Year $-3.90
  • Growth Rate Est. (year over year) +60.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.86 +14.66%
on 07/30/26
8.90 -24.49%
on 08/20/26
+0.71 (+11.76%)
since 07/28/26
3-Month
5.75 +16.85%
on 07/27/26
8.90 -24.49%
on 08/20/26
-1.43 (-17.54%)
since 05/28/26
52-Week
4.75 +41.47%
on 03/06/26
12.30 -45.37%
on 04/07/26
-1.58 (-19.03%)
since 08/28/25

Most Recent Stories

More News
Longeveron Announces 1-for-10 Reverse Stock Split

MIAMI, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related...

LGVN : 6.72 (-1.18%)
LGVNR : 0.0005 (-37.50%)
Longeveron Announces 1-for-10 Reverse Stock Split

Longeveron Announces 1-for-10 Reverse Stock Split

LGVN : 6.72 (-1.18%)
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector MIAMI, Aug. 19,...

LGVN : 6.72 (-1.18%)
DERM : 7.47 (-0.80%)
IRD : 3.69 (-4.16%)
LGVNR : 0.0005 (-37.50%)
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

LGVN : 6.72 (-1.18%)
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

On track for September 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for hypoplastic left heart syndrome (HLHS), a rare pediatric...

LGVN : 6.72 (-1.18%)
LGVNR : 0.0005 (-37.50%)
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

LGVN : 6.72 (-1.18%)
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition

Longeveron selected as a Milestone 2 Awardee based on published clinical trial results which demonstrated laromestrocel increased 6-minute walk distance in patients with Aging-related Frailty MIAMI,...

LGVN : 6.72 (-1.18%)
LGVNR : 0.0005 (-37.50%)
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition

Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition

LGVN : 6.72 (-1.18%)
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

MIAMI, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic...

LGVN : 6.72 (-1.18%)
LGVNR : 0.0005 (-37.50%)
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

Longeveron to report Q2 2026 financial results and host investment community conference call and webcast on August 12, 2026....

LGVN : 6.72 (-1.18%)

Business Summary

Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.

See More

Key Turning Points

3rd Resistance Point 7.83
2nd Resistance Point 7.54
1st Resistance Point 7.13
Last Price 6.72
1st Support Level 6.43
2nd Support Level 6.14
3rd Support Level 5.73

See More

52-Week High 12.30
Fibonacci 61.8% 9.42
Fibonacci 50% 8.52
Fibonacci 38.2% 7.63
Last Price 6.72
52-Week Low 4.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.